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Edited by Hans-Dieter KlenkAbstract Recent experimental study found that OLE (olive leaf
extract) has anti-HIV activity by blocking the HIV virus entry
to host cells [Lee-Huang, S., Zhang, L., Huang, P.L., Chang,
Y. and Huang, P.L. (2003) Anti-HIV activity of olive leaf ex-
tract (OLE) and modulation of host cell gene expression by
HIV-1 infection and OLE treatment. Biochem. Biophys. Res.
Commun. 307, 1029; Lee-Huang, S., Huang, P.L., Zhang, D.,
Lee, J.W., Bao, J., Sun, Y., Chang, Y.-Tae, Zhang, J.Z.H.
and Huang, P.L. (2007) Discovery of small-molecule HIV-1 fu-
sion and integrase inhibitors oleuropein and hydroxytyrosol. Bio-
chem. Biophys. Res. Commun. 354, 872–878, 879–884]. As part
of a joint experimental and theoretical eﬀort, we report here
computational study to help identify and characterize the binding
complexes of several main compounds of OLE (olive leaf ex-
tract) to HIV-1 envelop protein gp41. A number of possible bind-
ing modes are found by docking oleuropein and its metabolites,
aglycone, elenolic acid and hydroxytyrosol, onto the hydrophobic
pocket on gp41. Detailed OLE-gp41 binding interactions and
free energies of binding are obtained through molecular dynam-
ics simulation and MM-PBSA calculation. Speciﬁc molecular
interactions in our predicted OLE/gp41 complexes are identiﬁed
and hydroxytyrosol is identiﬁed to be the main moiety for bind-
ing to gp41. This computational study complements the corre-
sponding experimental investigation and helps establish a good
starting point for further reﬁnement of OLE-based gp41 inhibi-
tors.
 2007 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Human immunodeﬁciency virus type 1 (HIV-1) envelope gly-
coprotein (Env) plays an important role in the early stage ofHIV
entry. Its surface subunit gp120 is responsible for virus binding
to receptor and co-receptors, and the transmembrane subunit
gp41 mediates fusion of the virus with the target cell [1–5].
The crystal structures of the six-helix bundle in gp41 show that
three helices from the N-peptides (the N-helices) associate to*Corresponding author. Fax: +1 212 260 7905.
E-mail address: john.zhang@nyu.edu (J.Z.H. Zhang).
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doi:10.1016/j.febslet.2007.05.029form the central trimeric coiled-coil and three helices from C-
peptide region (the C-helices) pack obliquely in an anti-parallel
conﬁguration into the highly conserved hydrophobic grooves on
the surface of the central coiled-coil. In each of the grooves,
there is a highly conserved hydrophobic deep cavity, formed
by the cavity-forming sequence in theNHR region, which is crit-
ical for viral fusion and stability of the 6-HB (helix bundle) [6].
Gp41 is an important target for developing AIDS drugs besides
RT (reverse transcriptase), protease and integrase. Inhibition of
gp41 can eﬀectively blockHIV-1 entry into human cells and thus
prevent new infection of AIDS virus [7–10].
Much eﬀort has been devoted toward developing eﬀective
small molecular inhibitors of gp41 with little success. The un-
ique 6-HB structure of gp41 makes it diﬃcult to identify a suit-
able small molecule inhibitor that can bind eﬀectively to gp41.
Recent experimental investigation by Lee-Huang and co-work-
ers has found that OLE (olive leaf extract) shows strong anti-
HIV activity. Their research shows that OLE inhibits acute
infection (new virus infection) and cell-to-cell transmission
(virus replication) of HIV-1 [11]. One of the suspected targets
for OLE action is HIV-1 gp41 which is responsible for HIV en-
try into normal cells. In order to establish HIV protein targets
of OLE and its inhibitory action at molecular level, a joint the-
oretical and experimental eﬀort has been carried out to help
achieve this goal [12]. OLE is known to contain a mixture of
polyphenolic compounds, among them oleuropein, oleuropein
aglycone, elenolic acid and hydroxytyrosol (see Fig. 1), which
are readily absorbed and bioavailable. The biological activities
of OLE are mainly derived from these compounds [13,14]. In
this work, we report computational study to help identify and
characterize speciﬁc actions of the main ingredients of OLE
and their binding interactions with gp41. To complement the
experimental investigation, we performed systematic computa-
tional studies to investigate possible binding complexes of
OLE/gp41 through molecular docking, MD (molecular dynam-
ics) simulation and free energy calculations. Speciﬁc binding
modes from docking studies are analyzed and MD simulation
is performed to study molecular interaction, binding mecha-
nism, stability of the binding complexes and binding aﬃnities
for oleuropein and several of its main metabolites with gp41.2. Computational methods
Each ligand was ﬁrst optimized at the AM1 level using the Gaussian
98 package [15] and the minimized structure was used to calculate the
HF/6-31G* electrostatic potential (ESP). The atomic charges used foration of European Biochemical Societies.
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Fig. 1. Compounds in OLE mixture: oleuropein (a), oleuropein aglycone (b), elenolic acid (c) and hydroxytyrosol (d).
2738 J. Bao et al. / FEBS Letters 581 (2007) 2737–2742molecular mechanics calculations were derived from the ESP by using
the RESP [16] program implemented in the AMBER 8.0 [17] package.
For the ligands we study here, the binding orientations were ﬁrst esti-
mated using AutoDock 3.0.5 [18]. There is a highly conserved large
hydrophobic cavity located at the N-terminal of N-36 coiled-coil core
structure, including conserved residues such as Leu565, Leu566,
Thr569, Val570, Trp571, Gly572, Ile573, Lys574, Leu576, and
Gln577 [6], occupying this cavity by small molecules will interrupt
the formation of six-helix fusion structure, thus inhibit the HIV mem-
brane fusion process. The preliminary docking studies show that the
hydrophobic cavity located at the N-terminal of the N36 trimer is a rel-
atively favorable site for the docking of small molecule. We thus used
this hydrophobic cavity to generate the receptor site and the energetic
grids for the docking calculations. To obtain all the possible binding
orientations, ﬂexible docking was performed in which single bonds
outside the rings were set free to rotate. During the docking process,
conformational search was performed using the Solis and Wets local
search method, and the Lamarckian genetic algorithm was applied
to ﬁnd minimum energy structure of the ligand–receptor complexes.
The docking structures obtained were then minimized in the ﬁxed pro-
tein using 200 steps of Steepest Descent followed by 2000 steps of Con-
jugate Gradient.
Molecular dynamics simulations were carried out using the SAN-
DER module of the AMBER8.0 program [17] with the ﬀ03 version
of Amber force ﬁeld [19]. For each gp41-ligand binding mode obtained
from AutoDock, about 10000 TIP3P water molecules with 10 A˚ buﬀer
were added around the complex. Eleven K+ counterions were added to
maintain the neutrality of the system. The simulations were carried out
at 300 K with a time step of 2.0 fs. The non-bonded cutoﬀ was set to
10.0 A˚ and SHAKE algorithm was applied for all the bonds involving
hydrogen atoms. After minimization of 1500 steps and equilibration
for 150 ps, complex conformations were collected every 1 ps for the
following 3 ns simulation. Finally, 100 snapshots were collected from
the region with stable ﬂuctuation for post-processing analysis and
for free energy calculations.
For each snapshot collected during the MD simulation, both li-
gand–protein interaction energies (DEvdw, DEelec) and the electrostatic
contribution (DGPB) to the solvation energy were calculated with the
PBSA program of AMBER 8.0 [17]. Here, the single trajectory ap-
proach is applied to estimate the energies. This approach means that
the thermodynamic data are extracted from a single trajectory of the
protein–ligand complex based on the assumption that the bound pro-
tein and bound ligand conformations are similar to their free confor-
mations. Estimation of energies in this manner has proven successful
in many studies. Part of the reason for the success of this approach is
the cancellation of errors that hides the eﬀect of incomplete sampling.
A logically better approach, limited in practice due to larger ﬂuctua-
tions and errors, is the use of separate trajectories where the energies
are estimated from three separate MD trajectories of protein–ligand
complex, free protein, and free ligand. Due to sampling limitations,
the separate trajectory approach appeared to be signiﬁcantly less sta-
ble in numerical study. The non-polar part of the solvation energy
(DGSA) is estimated using the simple empirical relation: DGSA =
cA + b, where A is the solvent-accessible surface area that is esti-
mated using Sanner’s algorithm implemented in the MSMS program[20] with a solvent probe radius of 1.4 A˚ and the PARSE atomic radii
parameters [21]. c and b are empirical constants and are set to
0.00542 and 0.92 kcal/mol, respectively [21]. The energy terms
obtained with MM-PBSA approach [22] were then averaged over
100 time frames. The normal mode calculation to estimate the entro-
py contribution is somewhat problematic and time-consuming [23,24].
One normal mode calculation was performed by using Nmode
module in the AMBER 8.0 [17] for each ligand and only residues
at the nearest two N36 helices were included in the entropy calcula-
tions.3. Results and discussion
Studies were carried out to dock, respectively, oleuropein and
its three metabolites to the hydrophobic pocket of gp41. In gen-
eral, molecular docking give quite diﬀerent lowest energy orien-
tations, especially for a molecule with many degrees-of-freedom
(DOF) and the weak binding. Therefore, in order not to miss
the energetically favorable orientations, our docking result is
analyzed by cluster analysis and several diﬀerent binding modes
with the best scores and the largest populations for each mole-
cule were selected for further MD study and analysis. Three
nanosecond molecular dynamics simulations were performed
for all the binding modes of oleuropein, oleuropein aglycone,
elenolic acid and hydroxytyrosol. Although for most of the
modes the systems were well equilibrated after 400 ps MD sim-
ulations, the 100 snapshots (every fourth snapshot of the 400
collected snapshots) for further processing analysis were se-
lected after equilibration with the lowest RMSD ﬂuctuations.
The binding structure for the mode with the lowest free energy
for each ligand was further analyzed.
All the binding energies and entropies from the normal
mode analysis have been calculated and listed in Table 1.
The binding mode that has the lowest binding free energy is
supposed to be the most favorable binding mode. Our result
shows that most binding modes with the lowest free energies
have large negative electrostatic interaction energies, implying
that the electrostatic interaction plays a dominant role in sta-
bilizing the ligand–gp41 complex. We notice, however, that
elenolic acid is the only exception with relatively less attractive
electrostatic interaction as shown in Table 1. As a result, we
could not ﬁnd any elenolic acid–gp41 complexes with negative
binding free energies.
Considering various binding modes for each ligand, com-
plexes of gp41 with oleuropein and oleuropein aglycone (oleu-
ropein non-sugar compound) have relatively larger van der
Table 2
The percent occupancies of the hydrogen bonds between two hydroxyl
groups of the ligands and Gln577 on N36 peptide
Ligand Gln577/575
Oleuropein 33 48
Oleuropein aglycone 67 49
Elenolic acid – –
Hydroxytyrosol 46 67
Table 1
Binding free aenergies of diﬀerent binding modes of oleuropein and its metabolites to HIV-1 gp41
Ligand Mode DEintra DEvdw DEelec DEinter DDGPB DDGSA DDGMMPBSA bDDGcorr TDS DG
Oleuropein I 91.52 24.44 25.08 49.52 26.02 4.27 27.77 25.85 21.23 4.62
II 89.60 34.30 8.20 42.50 28.14 5.25 19.62 19.62 1.61
III 95.81 38.84 6.62 45.45 29.13 5.41 21.74 15.53 5.7
IV 90.49 27.11 16.60 43.71 32.19 4.28 15.79 14.90 6.33
Oleuropein aglycone I 55.56 33.10 23.31 56.41 32.96 4.50 27.96 26.90 19.86 7.04
II 55.70 26.62 11.87 38.49 31.30 4.46 11.64 10.44 9.42
III 54.50 22.12 6.09 28.21 11.83 3.45 19.82 19.82 0.04
IV 55.08 26.71 2.70 29.41 18.32 4.12 15.21 14.63 5.23
Elenolic acid I 37.64 19.03 12.58 31.61 26.37 3.65 8.80 8.84 14.73 5.89
II 37.71 20.17 9.51 29.69 19.43 3.39 13.65 13.52 1.21
III 37.58 24.60 10.78 35.38 29.22 3.61 9.77 9.77 4.96
Hydroxytyrosol I 16.27 14.39 29.56 43.95 27.62 3.25 19.57 19.04 14.74 4.3
II 15.74 19.83 13.66 33.49 20.69 3.32 16.12 16.12 1.38
aAll energies are in kcal/mol.
bThe corrected DDGcorr is calculated by adding the relative intramolecular energy of the ligand to the DGMMPBSA.
J. Bao et al. / FEBS Letters 581 (2007) 2737–2742 2739Waals energy DEvdw. This arises from the diﬀerent molecular
sizes, geometries and chemical groups of the ligands. For
example, oleuropein, with the hydrophilic glucoside moiety,
displays partial desolvation conformations during the simula-Fig. 2. Root-mean-square deviations (A˚) of oleuropein (a), oleuropein aglyc
structure (black line) for 3 ns MD simulations.tion. As a result, oleuropein has an electrostatic free energy
DDGPB close to that of small ligands. The elenolic acid and
hydroxytyrosol, which are actually two counter components
of oleuropein aglycone, are of smaller molecular sizes in com-
parison to oleuropein aglycone. The van der waals energy of
oleuropein aglycone is approximately the summation of elen-
olic acid and hydroxytyrosol. Although the electrostatic inter-
action energy of oleuropein aglycone with gp41 is somewhat
undermined comparing to that of hydroxytyrosol, it can still
form relatively stable hydrogen bond with the protein. Consid-
ering all these eﬀects together, oleuropein aglycone has the
lowest binding free energy, thus among the four compounds,
it’s the most energetically favorable ligand for binding to
gp41.one (b), elenolic acid (c), hydroxytyrosol (d) and gp41 ﬁve-helical core
2740 J. Bao et al. / FEBS Letters 581 (2007) 2737–2742From the typical complex structure of each ligand, we found
that the binding sites of the two indole rings of Trp631 and
Trp628 serve as the most important binding region (Fig. 3).
The binding site of Trp628 is the most favorable site of
small-size ligand (elenolic acid and hydroxytyrosol) binding.
For hydroxytyrosol, the stable hydrogen bonds between two
hydroxyl groups at the dihydroxyl phenol ring and the
carboxyl oxygen at the sidechain of Gln577 leads to strong
electrostatic interaction. Although generally Gln has a hydro-Fig. 3. Interactions of C43 residues, oleuropein and its metabolites with the ca
cavity. The two Trp residues are colored purple. Binding of oleuropein (b), ol
cavity. The neighboring residues are drawn and labeled.phobic side chain and has hydrophobic interactions with Trp
side chain in the ﬁve-helical bundle gp41, our simulations
showed that the carboxyl oxygen on the side chain of
Gln577/Gln575 plays the role of hydrogen bonding acceptor.
Table 2 lists the hydrogen bonding % occupancies at the two
hydroxyl groups for each ligand with 3.0 A˚ and 120 cutoﬀs
for the distance and angle. Combining the free energy data
and the hydrogen bonding conformations (Figs. 3 and 4),
the binding site of Trp628 seems to be the best position forvity on the N-terminal surface of N36. (a) C34 residues docked into the
europein aglycone (c), elenolic acid (d), and hydroxytyrosol (e) with the
J. Bao et al. / FEBS Letters 581 (2007) 2737–2742 2741the formation of hydrogen binding. The dihydroxyl phenol
moiety from oleuropein located at near the binding site of
hydroxytyrosol has similar electrostatic interactions with the
protein. However, because of the existence of the glucoside
moiety, the secoiridoid moiety can hardly interact with the
protein.
Due to the hydrophobicity of the binding site, the existence
of the glucoside moiety of the oleuropein induces large struc-
tural ﬂuctuations (Fig. 2). The glucoside moiety is completely
exposed to the solvent molecules during the MD simulation,
thus weakens the electrostatic interactions at the dihydroxyl
phenol moiety and hydrophobic interactions at the secoiridoid
moiety. From the free energy analysis it is clear that the hydro-
gen bonding between Gln577/Gln575 and dihydroxyl phenol
ring play the crucial role in stabilizing the binding complexes
and increasing the binding aﬃnities; the hydrophobic interac-
tions induced by secoiridoid moiety provide additional stabili-
zations, although the hydrogen bonding eﬀect is slightly
weakened in oleuropein aglycone binding compared to
hydroxytyrosol. The elenolic acid does not have favorable elec-
trostatic interaction with gp41, but it serves as a useful struc-
tural unit in oleuropein aglycone.Table 3
Inhibitions on HIV fusion core formation of oleuropein and hydroxy-
tyrosol
Compound Inhibitory activity EC50 (nM)
a of
Fusion core formation
6HB(N36 + C34)
N-PAGEb CDSAc
Oleuropein 66 ± 5 62 ± 6
Hydroxytyrosol 58 ± 8 60 ± 4
aEC50: eﬀective concentration at 50% inhibition.
bN-PAGE: native polyacrylamide gel electrophoresis.
cCDSA: circular dichroism spectroscopy analysis. Values are
means ± S.D. of triplicates in three independent determinations.4. Conclusions
The binding complexes of oleuropein and its metabolites
with HIV-1 gp41 ﬁve-helical core structure are simulated from
docking and MD calculations. Free energy analysis of the pro-
tein–ligand ensemble using MM/PBSA model was used to
identify the most possible binding modes. Our simulation
shows that the conserved hydrophobic cavity located at the
N-terminal of gp41 core N36 trimer structure is the most pos-
sible binding site. The electrostatic interaction plays the key
role in determining the aﬃnities of the ligand binding, and
as a result, the dihydroxyl phenol ring is the crucial group
for the OLE’s anti-HIV membrane fusion activity. Because
of its hydrophilic property, the existence of the glucoside moi-
ety in the oleuropein molecule undermines the binding aﬃnity.
The binding site for oleuropein and its metabolites is located at
the corresponding N36 cavity of two indole rings of Trp631
and Trp628. Since the Trp628 and Trp631 side chains andFig. 4. The hydrogen binding structures of gp41 binding with oleuropein (
hydrogen bonds to the ligands are GLN575.neighboring side chains (Ile635 and Asp632) occupy the prom-
inent cavity, and the corresponding N36 residues are highly
conserved and critical in membrane fusion activity, it may sug-
gest that our predicted complexes are consistent with the pre-
vious bioactivity experiments and can serve as a starting point
of molecular modiﬁcation and new ligand design for HIV-1
membrane fusion inhibition.
Although there is no available crystal structure of small mol-
ecule binding with gp41 coiled-coil structure, it is worthwhile
to note several recent experimental results. The direct experi-
mental proof is from the determinations of binding eﬀects of
oleuropein and hydroxytyrosol with HIV-gp41 fusion core
by using native polyacrylamide gel electrophoresis (PAGE)
and circular dichroism spectroscopy. Table 3 lists EC50s for
oleuropein and hydroxytyrosol for the fusion core formation
process from the native PAGE analysis and circular dichroism
spectroscopy analysis (CDSA). These results show dose depen-
dent inhibitions of fusion core for both oleuropein and
hydroxytyrosol, total inhibition is achieved at 100 nM oleu-
ropein and hydroxytyrosol with EC50s at 66 and 58 nM respec-
tively in native PAGE and 62 and 60 nM respectively in
CDSA. Two fusion inhibitors, NB-2 [25] and S2986 [26], which
share similar phenolic moiety with hydroxytyrosol and oleu-
ropein aglycone, are reported to exhibit HIV fusion inhibition
eﬀects and bind to the conserved hydrophobic pocket of N36
coiled-coil structure, however, NB-2 is claimed to form salt
bridge with charged residue K574 at N36 core structure, which
is diﬀerent from the hydroxytyrosol binding mechanism wea), oleuropein aglycone (b), and hydroxytyrosol (c). The residue that
2742 J. Bao et al. / FEBS Letters 581 (2007) 2737–2742proposed. A comprehensive simulation and comparison of
known small molecules with HIV fusion inhibition eﬀects is
in preparation. Nevertheless, our computational results are
in general agreement with these corresponding experimental
studies and provided much needed chemical information for
OLE action on HIV proteins at detailed molecule level based
on which rational reﬁnement of chemical structures of the
OLE compounds can be envisioned for developing more po-
tent inhibitors of gp41.
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